4CPS-088 Direct-acting antivirals for the treatment of hepatitis c virus infection: a real-world data analysis

BACKGROUND: The use of direct-acting antivirals (DAAs) in hepatitis C virus (HCV) patients has been a controversial issue over the past years in medicine. It has changed the HCV treatment paradigm, becoming a disease that can be cured. An extensive literature has documented the efficacy of these age...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Eur J Hosp Pharm
Main Authors: Sacristan, A Garcia, Martínez-Sesmero, JM, Ambel, H Quirós, Lista, FJ Manzano, Barahona, A Dominguez, Suarez, S Gonzalez, Gómez, P Moya
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Group 2018
Assuntos:
Section 4: Clinical pharmacy services
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535248/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.179
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares